JZ
Jason Zemansky B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Werewolf Therapeutics
HOWL
$61.7M
| $1.35 | $8 |
493%
upside
| Buy |
25 Aug ‘25
13 days ago |
|
2
Rocket Pharmaceuticals
RCKT
$354M
| $3.28 | $10 |
205%
upside
| Buy |
20 Aug ‘25
18 days ago |
|
3
Insmed
INSM
$30.7B
| $145.10 | $109 |
25%
downside
| Buy |
11 Jun ‘25
2 months ago |
|
4
Keros Therapeutics
KROS
$633M
| $15.59 | $18 |
15%
upside
| Neutral |
10 Jun ‘25
3 months ago |
|
5
Cytokinetics
CYTK
$6.34B
| $53.01 | $54 |
2%
upside
| Neutral |
15 Apr ‘25
4 months ago |
|
6
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $31 |
43%
upside
| Buy |
1 Apr ‘25
5 months ago |
|
7
Arcus Biosciences
RCUS
$1.3B
| $12.19 | $17 |
39%
upside
| Neutral |
19 Feb ‘25
6 months ago |
|
8
Kura Oncology
KURA
$713M
| $8.22 | $29 |
253%
upside
| Buy |
22 Nov ‘24
9 months ago |
|
9
Syndax Pharmaceuticals
SNDX
$1.47B
| $17.04 | $31 |
82%
upside
| Buy |
15 Aug ‘24
1 year ago |
|
10
Esperion Therapeutics
ESPR
$540M
| $2.68 | $2.50 |
7%
downside
| Underperform |
20 Jun ‘24
1 year ago |
|
|
KLRS
11
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $4.62 | $23 |
398%
upside
| Underperform |
26 Dec ‘23
1 year ago |
|
|
OKUR
12
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $2.75 | $230 |
8,264%
upside
| Buy |
3 Jul ‘23
2 years ago |
|
13
Q32 Bio
QTTB
$20.4M
| $1.67 | $162 |
9,601%
upside
| Buy |
22 Feb ‘22
3 years ago |
|